Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
Generated Narrative: Immunization TCC02-IMMUN3-HCP1-ORG1-ROLE
Author of the content: PractitionerRole
CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel
Entry Resource Cross References
- entry: Identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/7f7a308a-63f7-4be1-a329-0a33e08b4645- container: Identifier: URI/urn:uuid:9686dae0-448c-49f8-9c78-2db1aa95b921
- relationcode: replaces
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/fe53381d-ade3-4a95-8bd1-033b76eadec2
status: Completed
vaccineCode: FSME-Immun CC
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-07-30
recorded: 2021-08-21 00:00:00+0200
lotNumber: ABC-7524GHA
route: Intramuscular use
| Actor |
| PractitionerRole |
| TargetDisease | DoseNumber[x] |
| Tickborne encephalitis | 1 |